EcoDrugPlus

Proteasome Subunit Beta Type-9

Ensembl ID : ENSLCAG00010009232
Gene Symbol: LOC108881898
4 Cross references
207 Possible Orthologues:

Proteasome Subunit Beta Type-9

Ensembl ID : ENSLCAG00010020799
Gene Symbol: LOC108881898
4 Cross references
207 Possible Orthologues:

Protein Arginine Methyltransferase 5

Ensembl ID : ENSLCAG00010007248
Gene Symbol: LOC108883946
4 Cross references
198 Possible Orthologues:

Protein Kinase C Beta

Ensembl ID : ENSLCAG00010002871
Gene Symbol: PRKCB
4 Cross references
207 Possible Orthologues:

Protein Kinase C Beta Type

Ensembl ID : ENSLCAG00010026208
Gene Symbol: LOC108888464
4 Cross references
223 Possible Orthologues:

Protein Kinase C Delta

Ensembl ID : ENSLCAG00010022511
Gene Symbol: PRKCD
1 Cross references
202 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSLCAG00010018081
Gene Symbol: PRKCE
4 Cross references
249 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSLCAG00010002348
Gene Symbol: PRKCE
1 Cross references
252 Possible Orthologues:

Protein Kinase C, Alpha, A

Ensembl ID : ENSLCAG00010025237
Gene Symbol: PRKCAA
1 Cross references
213 Possible Orthologues:

Protein Kinase C, Delta A

Ensembl ID : ENSLCAG00010018192
Gene Symbol: PRKCDA
4 Cross references
204 Possible Orthologues:

Protein Kinase C, Eta, A

Ensembl ID : ENSLCAG00010023818
Gene Symbol: PRKCHA
4 Cross references
224 Possible Orthologues:

Protein Kinase C, Theta

Ensembl ID : ENSLCAG00010009934
Gene Symbol: LOC108895932
4 Cross references
204 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).